Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin
Risk of Type 2 Diabetes: Insulin resistance is a major precursor to the development of type 2 diabetes
J Natl Cancer Inst 97: 541-542, 2005
[ Links ] 37
Regulatory Pathway Health Canada approval typically follows FDA approval by several months to a year for obesity medications
More importantly, you might find the side effects harder to handle
US$ 20.14
US$ 25.33
US$ 28.26
US$ 27.49
US$ 29.53
